Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03608371 · ClinicalTrials.gov registry record · Phase 2

BTRX-246040 Study in Participants With Parkinson's Disease With Motor Fluctuations

A Phase 2 study of Parkinson Disease and Motor Disorder, sponsored by BlackThorn Therapeutics.

Completed
Registry status
Phase 2
Development phase
24
Enrollment target
4
Study locations

NCT03608371 is a Phase 2 study of Parkinson Disease and Motor Disorder that has completed, run by BlackThorn Therapeutics. The registered enrollment target is 24 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03608371, a Phase 2 study of Parkinson Disease and Motor Disorder, has completed, sponsored by BlackThorn Therapeutics.

COMPLETED
Registry status
Phase 2
Development phase
24 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to assess the safety, tolerability, pharmacokinetics and efficacy of BTRX-246040 in participants with Parkinson's Disease who have motor fluctuations and predictable early morning off periods.

Conditions Studied

Parkinson Disease Motor Disorder

Interventions

  • DRUG Placebo
  • DRUG BTRX-246040

Study Locations (4)

Florida

  • BlackThorn Investigator Site - Hallandale

Michigan

  • BlackThorn Investigator Site - Farmington Hills

North Carolina

  • BlackThorn Investigator Site - Durham

Texas

  • BlackThorn Investigator Site - Dallas

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2018-08-31
Est. Completion 2019-04-23
Phase Phase 2

Sponsor

BlackThorn Therapeutics

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03608371

The ClinicalTrials.gov registry entry for NCT03608371 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is BlackThorn Therapeutics, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03608371 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Florida, Michigan, North Carolina.

Frequently Asked Questions

What is clinical trial NCT03608371 about?

NCT03608371 is a clinical study titled "BTRX-246040 Study in Participants With Parkinson's Disease With Motor Fluctuations". The purpose of this study is to assess the safety, tolerability, pharmacokinetics and efficacy of BTRX-246040 in participants with Parkinson's Disease who have motor fluctuations and predictable early morning off periods.

What is the current status of trial NCT03608371?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2018-08-31. Estimated completion is 2019-04-23.

What conditions does trial NCT03608371 study?

This clinical trial studies the following conditions: Parkinson Disease, Motor Disorder.

What interventions are being tested in trial NCT03608371?

The interventions under investigation include: Placebo (DRUG), BTRX-246040 (DRUG).

Who is sponsoring clinical trial NCT03608371?

This trial is sponsored by BlackThorn Therapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03608371 being conducted?

This trial has 4 study locations across Florida, Michigan, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson Disease

All registered trials for this condition

Motor Disorder

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.